Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-02-21Clinical Trial Update: Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia. [Phase 2]
Phase 2 trial updating peptide vaccination targeting PD-L1 and PD-L2 in untreated chronic lymphocytic leukemia (Chronic Lymphocytic Leukemia…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL) [Phase 2]
Phase 2 study evaluating the combination of ibrutinib and venetoclax in treatment-naive chronic lymphocytic leukemia/small lymphocytic lymph…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating T cells engineered with fully-human anti-CD19 and anti-CD20 CARs for B-cell malignancies and Hodgkin lymphoma; the …
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy [Phase 2]
This clinical trial update reports results from a Phase 2 study of acalabrutinib (ACP-196) in subjects with relapsed/refractory chronic lymp…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL) [Phase 3]
Phase 3 trial comparing acalabrutinib (ACP-196) to ibrutinib in previously treated high-risk chronic lymphocytic leukemia; status is active …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients
A completed clinical trial evaluating quality assurance of secondary immunodeficiencies in patients with chronic lymphocytic leukemia or mul…
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy [Phase 3]
Phase 3 trial update on lenalidomide maintenance after first-line therapy in high-risk chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion [Phase 2]
Phase 2 trial update on ABT-199 (venetoclax) in relapsed/refractory or previously untreated chronic lymphocytic leukemia with 17p deletion; …
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I) [Phase 2]
Phase 2 trial assessing SHINGRIX vaccine response in chronic lymphocytic leukemia patients, including those treated with BTK inhibitors; stu…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I) [Phase 2]
Phase 2 trial evaluating HEPLISAV-B hepatitis B vaccine in patients with chronic lymphocytic leukemia, including those treated with BTK inhi…
-
CLINICAL_TRIALS trial_result · 2021-12-02Clinical Trial Update: Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL [Phase 2]
Phase 2 trial evaluating consolidative therapy with ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphoc…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Venetoclax and Ibrutinib in Patients With Relapsed/Refractory CLL or SLL [Phase 2]
Phase 2 trial evaluating venetoclax plus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic ly…
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 1, Phase 2]
Phase 1/2 open-label dose-finding trial evaluating CC-122 in combination with ibrutinib and obinutuzumab for chronic lymphocytic leukemia/sm…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 trial update on prognostic factors for frontline fludarabine, cyclophosphamide, and rituximab (FCR) therapy in chronic lymphocytic l…
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD. [Phase 2]
Phase 2 trial evaluating induction with venetoclax and ibrutinib followed by ibrutinib and obinutuzumab in CLL patients with MRD.
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL [Phase 2]
Phase 2 trial evaluating acalabrutinib in patients with relapsed/refractory and treatment-naïve deletion 17p chronic lymphocytic leukemia/sm…
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL [Phase 1, Phase 2]
Phase I/II trial evaluating different doses and schedules of milatuzumab (hLL1) in patients with chronic lymphocytic leukemia/lymphoma; stud…
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL [Phase 1, Phase 2]
Clinical trial update for subcutaneously administered veltuzumab (hA20) in non-Hodgkin lymphoma and chronic lymphocytic leukemia; study comp…
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Study Evaluating Venetoclax in Subjects With Hematological Malignancies [Phase 1, Phase 2]
Clinical trial update for venetoclax in hematological malignancies at phases 1 and 2; study status completed.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation [Phase 3]
A Phase 3 trial investigating Zebutinib in combination with immunochemotherapy for newly treated chronic lymphocytic leukemia patients witho…
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial update evaluating front-line use of ofatumumab in elderly patients with chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 study evaluating the efficacy and safety of Tenalisib (RP6530) in relapsed/refractory chronic lymphocytic leukemia, sponsored by Rhi…
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating BI-1206 in combination with an anti-CD20 antibody for CD32b-positive B-cell lymphoma or leukemia; study …
-
CLINICAL_TRIALS trial_result · 2021-07-01Clinical Trial Update: A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue [Phase 2]
Phase 2 pilot trial evaluating the impact of cytotoxic therapy and/or radiotherapy on cancer-related sleep disturbances in patients with leu…
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma [Phase 2]
Phase 2 trial evaluating CD8+ memory T-cells as consolidative therapy after donor non-myeloablative hematopoietic cell transplant in leukemi…